Global Needle-free Drug Delivery Devices Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品编码 659351
出版日期 内容资讯 英文 108 Pages
商品交期: 2-3个工作天内
Back to Top
无针头药物输送设备的全球市场:各技术、应用、地理的成长、趋势及预测(2018年~2023年) Global Needle-free Drug Delivery Devices Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日期: 2018年06月12日内容资讯: 英文 108 Pages




第1章 简介

  • 市场定义

第2章 调查方法

第3章 摘要整理

第4章 主要预测

第5章 市场概要

  • 目前市场方案
  • 波特的五力分析
    • 供应商谈判力
    • 消费者谈判力
    • 新加入厂商的威胁
    • 替代产品及服务的威胁
    • 产业内的竞争

第6章 成长要素,阻碍因素,机会,课题分析(DROC)

  • 市场成长要素
    • 慢性疾病及生活习惯障碍的流行
    • 药物的自我给药趋势
    • 最小侵入性设备的技术的进步
  • 市场阻碍因素
    • 严格的法规结构
    • 微针贴片的使用伴随的限制
  • 市场机会
  • 主要课题

第7章 市场区隔

  • 各技术
    • 吸入器
    • 喷射注射器
    • 新品种的针
    • 经皮吸收贴片
    • 其他
  • 各应用领域
    • 胰岛素输送
    • 疫苗接种
    • 疼痛管理
    • 其他
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第8章 竞争情形

  • M&A分析
  • 协定,合作,伙伴关系
  • 新产品的销售

第9章 主要企业

  • 3M
  • Akra Dermojet
  • Antares Pharma
  • D'Antonio Consultants International Inc.
  • Endo Pharmaceuticals Inc.
  • Penjet Corporation
  • PharmaJet
  • Valeritas Inc.
  • Zogenix Inc.

第10章 市场未来展望

Product Code: 61712

The global needle-free drug delivery devices market is expected to register a CAGR of approximately 9.7% over the forecast period of 2018-2023. Needle-free drug delivery injects the biologics without pain, anxiety, and need for handling the needles, and the market studied is primarily driven by the prevalence of chronic diseases and technological advancements in the field. By region, owing to the presence of a large target population suffering from chronic diseases, improving healthcare infrastructure in several countries, and prospering economies attracting multinational biopharmaceutical companies to invest in India, China, and other South Asian countries, it is estimated that Asia-Pacific has a high-growth potential during the forecast period.

Inclination toward Self-administration of Drugs

As modern lifestyle encourages independence, the way people use medications also gets affected. Self-administration of insulin is the state-of-the-art technology in diabetes care. Although with through technological development, the process is also advancing toward other medical areas, such as oncology and hormone therapy. The recent years have witnessed a high demand for pens and auto-injectors. There are several universities, hospitals, and research centers, which are collaborating and sponsoring the trials for needle-free jet injection across the globe, mainly in the United States, United Kingdom, and China. In the later half of 2017, a spin-out, Portal Instruments of Massachusetts Institute of Technology, collaborated with Takeda Pharmaceuticals, for the development and commercialization of PRIME, for testing antibodies in patients with ulcerative colitis or Crohn's disease. Therefore, with partnerships and technological advancements, the inclination toward self-administration of drugs is expected to boost the growth of the market studied, over the forecast period.

The other vitals factors driving the market studied are - rising prevalence of chronic diseases and lifestyle disorders and technological advancements in the minimally invasive devices market.

Limitations Associated with Micro-needle Patches

There are considerable limitations associated with micro-needle patches, in practical and economic terms. The micro-needle arrays have a restricted amount of drug that can be coated over a finite surface area of the micro-needle structures, thereby creating issues of adequate physio-chemical properties. In addition, the deposition of polymer in skin due to micro-needle, potential clogging of the needle openings with tissue during skin insertion, and flow resistance due to dense dermal tissue make them undesirable for use. Moreover, the silicon used is expensive and have elaborated fabrication, long fabrication times, and complex multi-step processing. There are several other associated restrictions, creating significant variation in results, based on analysis of the micro-needle penetration. Thus, the barriers associated with the micro-needle patches limit the growth of the needle-free drug delivery devices market, over the forecast period.

Asia-Pacific Offers Significant Opportunities

Asia-Pacific is expected to promise considerable growth opportunities over the forecast period, in the market studied. Large patient pools of chronic diseases, particularly diabetes, cardiovascular diseases, and cancer, are major drivers in the emerging markets. Several universities and research centers across China, Thailand, Vietnam, and South Korea have collaborated with companies or hospitals, to conduct the trials registered in clinicaltrial.gov. These are funded by the governments and companies from the developed markets. Thus, over the forecast period, the region is expected to witness the highest growth rate.

Key Developments in the Market:

  • May 2018 - Antares Pharma Inc. received USD 4.75 million from Ferring Pharmaceuticals, for the sale of Antares' worldwide rights for the Zomajet needle-free auto-injector device.
  • May 2018 - Namaste Technologies signed a definitive agreement with Inolife R&D Inc., wherein Namaste is granted exclusive rights for needle-free technologies, for applications of medical cannabis.

Reasons to Purchase this Report:

  • Current and future of needle-free drug delivery devices market in the developed and emerging economies
  • Analysis of various perspectives of the market, with the help of Porter's five forces analysis
  • The segment that is expected to dominate the market
  • The regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report:

This report can be customized to meet your requirements. Please connect with our representative, who will ensure that you to get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1. Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1. Current Market Scenario
  • 5.2. Porter's Five Forces Analysis
    • 5.2.1. Bargaining Power of Suppliers
    • 5.2.2. Bargaining Power of Consumers
    • 5.2.3. Threat of New Entrants
    • 5.2.4. Threat of Substitute Products and Services
    • 5.2.5. Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1. Market Drivers
    • 6.1.1. Rising Prevalence of Chronic Diseases and Lifestyle Disorders
    • 6.1.2. Inclination toward Self-administration of Drugs
    • 6.1.3. Technological Advancements in Minimally Invasive Devices
  • 6.2. Market Restraints
    • 6.2.1. Stringent Regulatory Framework
    • 6.2.2. Limitation Associated with the Use of Micro-needle Patches
  • 6.3. Opportunities
  • 6.4. Key Challenges

7. Market Segmentation

  • 7.1. By Technology
    • 7.1.1. Inhaler
    • 7.1.2. Jet Injector
    • 7.1.3. Novel Needle
    • 7.1.4. Transdermal Patch
    • 7.1.5. Others
  • 7.2. By Application
    • 7.2.1. Insulin Delivery
    • 7.2.2. Vaccination
    • 7.2.3. Pain Management
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • United States
      • Canada
      • Mexico
    • 7.3.2. Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
      • Rest of Europe
    • 7.3.3. Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 7.3.4. Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • 7.3.5. South America
      • Brazil
      • Argentina
      • Rest of South America

8. Competitive Landscape

  • 8.1. Merger and Acquisition Analysis
  • 8.2. Agreements, Collaborations, and Partnerships
  • 8.3. New Product Launches

9. Key Players

  • 9.1. 3M
  • 9.2. Akra Dermojet
  • 9.3. Antares Pharma
  • 9.4. D'Antonio Consultants International Inc.
  • 9.5. Endo Pharmaceuticals Inc.
  • 9.6. Penjet Corporation
  • 9.7. PharmaJet
  • 9.8. Valeritas Inc.
  • 9.9. Zogenix Inc.

List not Exhaustive

10. Future of the Market

Back to Top